The Limited Times

Now you can see non-English news...

Covid-19: Pfizer and BioNTech find their vaccine effective against British and South African variants

2021-01-28T08:26:00.944Z


The two companies still specify "watch for emerging variants" and say they are "ready to react" if one of these mutations were to resist the vaccine.


The Pfizer-BioNTech vaccine retains the vast majority of its efficacy against the main mutations of the English and South African variants of the coronavirus causing Covid-19, the two companies announced Thursday in a statement.

Read also: Will Covid-19 variants make re-infections more frequent?

In vitro tests "

have not shown the need for a new vaccine to deal with emerging variants,

" according to the companies, which however stress that they "

continue to monitor emerging variants and are ready to respond

" if a of these mutations was resistant to the vaccine.

Source: lefigaro

All business articles on 2021-01-28

You may like

Trends 24h

Latest

© Communities 2019 - Privacy

The information on this site is from external sources that are not under our control.
The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.